Ignite Creation Date:
2024-07-17 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483269
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-21
Brief Title:
Homologus PRP in the Infiltrative Treatment of Knee Osteoarthritis in Young Athletic Patients
Sponsor:
Istituto Ortopedico Rizzoli
Organization:
Istituto Ortopedico Rizzoli
Study Overview
Official Title:
Homologus PRP in the Infiltrative Treatment of Knee Osteoarthritis in Young Athletic Patients
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study consists of 3 phases enrollment infiltrative procedure and controls
Identification by specialized orthopedic medical staff belonging to the SC Orthopedic and Trauma Clinic II of the Rizzoli Orthopedic Institute of subjects who meet the study inclusion criteria Signing of informed consent form and completion of evaluation questionnaires
infiltrative procedure
Patients will be clinically evaluated before the infiltration procedure and at 1 3 6 and 12 months after treatment by trained medical personnel outcome assessors Questionnaires will be administered for clinical evaluations before treatment and at these clinical checkups during follow-up Any adverse events to treatment will also be assessed during follow-up visits The duration and extent of joint swelling and pain following infiltration will be reported and any drug therapies taken by the patient will be recorded
Identification by specialized orthopedic medical staff belonging to the SC Orthopedic and Trauma Clinic II of the Rizzoli Orthopedic Institute of subjects who meet the study inclusion criteria Signing of informed consent form and completion of evaluation questionnaires
infiltrative procedure
Patients will be clinically evaluated before the infiltration procedure and at 1 3 6 and 12 months after treatment by trained medical personnel outcome assessors Questionnaires will be administered for clinical evaluations before treatment and at these clinical checkups during follow-up Any adverse events to treatment will also be assessed during follow-up visits The duration and extent of joint swelling and pain following infiltration will be reported and any drug therapies taken by the patient will be recorded
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None